These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Effects of cholinesterase inhibitors on behavioural disturbances in Alzheimer's disease: a systematic review. Grimmer T; Kurz A Drugs Aging; 2006; 23(12):957-67. PubMed ID: 17154660 [TBL] [Abstract][Full Text] [Related]
47. Current pharmacotherapy for Alzheimer's disease. Lleó A; Greenberg SM; Growdon JH Annu Rev Med; 2006; 57():513-33. PubMed ID: 16409164 [TBL] [Abstract][Full Text] [Related]
48. Progress in Alzheimer's disease drug discovery: an update. Williams M Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484 [TBL] [Abstract][Full Text] [Related]
49. Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not? Xiong G; Doraiswamy PM Geriatrics; 2005 Jun; 60(6):22-6. PubMed ID: 15948662 [TBL] [Abstract][Full Text] [Related]
51. New treatment strategies for Alzheimer's disease: is there a hope? Aprahamian I; Stella F; Forlenza OV Indian J Med Res; 2013 Oct; 138(4):449-60. PubMed ID: 24434253 [TBL] [Abstract][Full Text] [Related]
52. Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic. Riordan KC; Hoffman Snyder CR; Wellik KE; Caselli RJ; Wingerchuk DM; Demaerschalk BM Neurologist; 2011 Mar; 17(2):121-3. PubMed ID: 21364371 [TBL] [Abstract][Full Text] [Related]
53. New therapies. New Alzheimer's treatments that may ease the mind. Helmuth L Science; 2002 Aug; 297(5585):1260-2. PubMed ID: 12193764 [No Abstract] [Full Text] [Related]
55. The efficacy and safety of memantine for the treatment of Alzheimer's disease. Matsunaga S; Kishi T; Nomura I; Sakuma K; Okuya M; Ikuta T; Iwata N Expert Opin Drug Saf; 2018 Oct; 17(10):1053-1061. PubMed ID: 30222469 [TBL] [Abstract][Full Text] [Related]
56. Behavioral effects of current Alzheimer's disease treatments: a descriptive review. Cummings JL; Mackell J; Kaufer D Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950 [TBL] [Abstract][Full Text] [Related]
57. Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease. Deardorff WJ; Grossberg GT Expert Opin Pharmacother; 2016 Sep; 17(13):1789-800. PubMed ID: 27450461 [TBL] [Abstract][Full Text] [Related]
58. Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials? Ehret MJ; Chamberlin KW Clin Ther; 2015 Aug; 37(8):1604-16. PubMed ID: 26122885 [TBL] [Abstract][Full Text] [Related]
59. Aspects of communication in Alzheimer's disease: clinical features and treatment options. Woodward M Int Psychogeriatr; 2013 Jun; 25(6):877-85. PubMed ID: 23522497 [TBL] [Abstract][Full Text] [Related]